Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC5629 Zinc17167211
Potent and selective agonist of peroxisome proliferator activated receptors-α (PPAR-α)
More description
DCC5628 Zinc17043486
Novel CDK6 inhibitor
More description
DCC5627 Zinc12909780
Novel dose-dependent inhibitor of TNF-α-induced NF-κB activation
More description
DCC5626 Zinc09410451
Potent Ebolavirus (EBOV) Inhibitor
More description
DCC5625 Zinc08985213
Novel effective immune check point inhibitor (ICI) against the suppression of T-cell activation, proliferation, and tumor cell eradication.
More description
DCC5624 Zinc08792355
Novel SIRT1 inhibitor
More description
DCC5623 Zinc08792229
Novel SIRT1 inhibitor
More description
DCC5622 Zinc08790006
Novel SIRT1 inhibitor
More description
DCC5621 Zinc08438472
Potent and selective agonist of peroxisome proliferator activated receptors-α (PPAR-α)
More description
DCC5620 Zinc06472206
Potent and selective agonist of peroxisome proliferator activated receptors-α (PPAR-α)
More description
DCC5619 Zinc05848961
Novel TNF-α inhibitor
More description
DCC5618 Zinc04574788
Novel potent small molecule lligand of miR-21, binding to the major groove of miR-21 hairpin conformation
More description
DCC5617 Zinc04515726
Novel effective immune checkpoint inhibitor (ICI) against the suppression of T-cell activation, proliferation, and tumor cell eradication.
More description
DCC5616 Zinc04502991
Novel TNF-α inhibitor
More description
DCC5615 Zinc04177596
Novel Nef Protein Inhibitor; Anti-HIV
More description
DCC5614 Zinc04085549
Novel blocker of AKT1-FAK interaction, reducing the stimulation of FAK phosphorylation in response to extracellular pressure in human SW620 colon cancer cells without affecting basal FAK phosphorylation
More description
DCC5613 Zinc03838680
Potent VEGFR-2 inhibitor
More description
DCC5612 Zinc01765622
Novel antagonist for mLST8
More description
DCC5611 Zinc00723145
The first nonpeptidic inhibitor of ovarian cancer cells growth targeting human thymidylate synthase (hTS)
More description
DCC5610 Zilpaterol
Growth promotant, acting as a ß-AR (ß-Adrenergic) agonist
More description
DCC5609 Ziconotide
Atypical analgesic agent for the amelioration of severe and chronic pain
More description
DCC5608 Z-ggr-amc
Fluorogenic peptide substrate for a direct fluorometric assay of urokinase, tissue-type plasminogen activator, trypsin and thrombin
More description
DCC5607 Zg-2033
Novel Potent and Orally Bioavailable Hypoxia-Inducible Factor 2α (HIF-2α) Agonist
More description
DCC5606 Zfh7116
Novel inhibitor of pro-HGF activation
More description
DCC5605 Zdwx-25
Novel daul inhibitor of GSK-3β (IC 50 = 71 nM) and DYRK1A (IC 50 = 103 nM) with good blood-brain barrier penetrability, inhibiting hyperphosphorylation of tau protein in okadaic acid (OKA)-induced SH-SY5Y cells
More description
DCC5604 Z-don-val-pro-leu-ome
Site specific inhibitor of tissue transglutaminase
More description
DCC5603 Zdlt-1
Novel potent HDAC inhibitor with IC50 values for class I HDACs 1, 2, and 3 below 4 nM, and IC50 for HDAC6 at 6 nM.
More description
DCC5602 Zdhhc Substrate Peptide
ZDHHC (zinc finger Asp-His-His-Cys) substrate peptide, a 15-mer peptide sequence from KRas4a plus two tryptophan residues
More description
DCC5601 zd6169
Potassium channel opener
More description
DCC5600 Zd6126
Vascular targeting agent (VTA)
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X